Last update 08 May 2025
Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.

Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.

Subsidiary Company|2017|Beijing Shi, China

Overview

Related

1
Drugs associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
Target
GHR
Mechanism
GHR agonists
Active Org.
Yifan Pharmaceutical Co., Ltd.Yifan Pharmaceutical Co., Ltd.
Originator Org.
Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Active Indication
Growth hormone deficiency
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
CTR20211232
/ CompletedPhase 1
注射用重组人生长激素 -Fc融合蛋白(F-899)在健康受试者单次给药的安全性、耐受性及药代动力学/药效学研究
[Translation] Safety, tolerability and pharmacokinetic/pharmacodynamic study of a single dose of recombinant human growth hormone-Fc fusion protein for injection (F-899) in healthy subjects
100 Clinical Results associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Login to view more data
100 Deals associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Recombinant human growth factor-Fc fusion protein(Yifan Pharmaceutical Research Institute (Beijing) Co., Ltd.)
 ( GHR )		-
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free